GlaxoSmithKline PLC
NYSE:GSK
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
34.0708
45.78
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
GSK Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for GSK is 51.12 USD with a low forecast of 38.36 USD and a high forecast of 74.15 USD.
GSK Last Price Targets
GlaxoSmithKline PLC
The latest public price target was made on Jul 2, 2024 by
Peter Welford
from
Jefferies
,
who expects
GSK
stock to
rise by 37%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Peter Welford
Jefferies
|
53
USD
Upside 37% |
3 months ago
Jul 2, 2024
|
GSK price target raised to $53 from $52.50 at Jefferies
TheFly
|
Vamil Divan
Guggenheim
|
36
USD
Downside 7% |
5 months ago
Apr 11, 2024
|
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
|
Mark Purcell
Morgan Stanley
|
85
USD
Upside 119% |
5 months ago
Apr 11, 2024
|
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GSK's stock price target?
Price Target
51.12
USD
According to Wall Street analysts, the average 1-year price target for GSK is 51.12 USD with a low forecast of 38.36 USD and a high forecast of 74.15 USD.
What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
6%
For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 3%. The projected CAGR for the next 3 years is 6%.
What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 7%. The projected CAGR for the next 3 years is 10%.
What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
18%
For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -6%. The projected CAGR for the next 3 years is 18%.
You don't have any saved screeners yet
